P

Inventor

KEIL STEFANIE

DE42 patents
⚠️ This page may combine multiple inventors who share the name “KEIL STEFANIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SANOFI AVENTIS DEUTSCHLAND

13 patents
US7335671B2Feb 26, 2008

Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND9 citations83
US7160911B2Jan 9, 2007

Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND14 citations83
US7148246B2Dec 12, 2006

Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND18 citations83
US7399777B2Jul 15, 2008

Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals

SANOFI AVENTIS DEUTSCHLAND5 citations63
US7259177B2Aug 21, 2007

Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND3 citations62
US7872034B2Jan 18, 2011

Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND0 citations51
US7365084B2Apr 29, 2008

Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND0 citations51
US7956077B2Jun 7, 2011

2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes

SANOFI AVENTIS DEUTSCHLAND0 citations50
US7541464B2Jun 2, 2009

7-azaindoles, pharmaceutical compositions and their therapeutic applications

SANOFI AVENTIS DEUTSCHLAND0 citations41
US7220876B2May 22, 2007

Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND0 citations41
US7709509B2May 4, 2010

Oxadiazolones and derivatives thereof as peroxisome proliferator-activated receptor (PPAR) delta agonists

SANOFI AVENTIS DEUTSCHLAND0 citations40
US7598281B2Oct 6, 2009

Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes

SANOFI AVENTIS DEUTSCHLAND0 citations39
US7538131B2May 26, 2009

2-{-3-′2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes

SANOFI AVENTIS DEUTSCHLAND0 citations39

SANOFI AVENTIS

13 patents
US7709481B2May 4, 2010

Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and methods for their use as pharmaceuticals

SANOFI AVENTIS4 citations61
US7655679B2Feb 2, 2010

Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositions

SANOFI AVENTIS2 citations61
US7772257B2Aug 10, 2010

Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use

SANOFI AVENTIS0 citations52
US7732471B2Jun 8, 2010

6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator—activated receptor (PPAR) ligands, process for their preparation and methods of use thereof

SANOFI AVENTIS0 citations52
US7612104B2Nov 3, 2009

Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use

SANOFI AVENTIS0 citations52
US7851493B2Dec 14, 2010

Phenyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals

SANOFI AVENTIS0 citations51
US7834030B2Nov 16, 2010

Phenyl-[1,2,4]-oxadiazol-5-one derivatives, pharmaceutical compositions and therapeutic use thereof

SANOFI AVENTIS0 citations51
US8003677B2Aug 23, 2011

2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as SCD inhibitors

SANOFI AVENTIS1 citations50
US7910612B2Mar 22, 2011

4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use

SANOFI AVENTIS0 citations41
US7858647B2Dec 28, 2010

N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use

SANOFI AVENTIS0 citations41
US7683181B2Mar 23, 2010

Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof

SANOFI AVENTIS0 citations41
US7468369B2Dec 23, 2008

Sulfonyl pyrrolidines, method for producing the same and their use as drugs

SANOFI AVENTIS0 citations39
US7732440B2Jun 8, 2010

Phenothiazin derivatives, method for the production thereof and use thereof as pharmaceuticals

SANOFI AVENTIS0 citations35

KEIL STEFANIE

7 patents

AVENTIS PHARMA GMBH

3 patents

AVENTIS PHARMA INC

2 patents

DEFOSSA ELISABETH

1 patent

SANOFI AVENTISDEUTSCHAND GMBH

1 patent

AVENTIS PARMACEUTICALS INC

1 patent

SANOFI SA

1 patent